In contrast, transgenic models of APOC3 overexpression not only display elevated plasma TG levels [114] but also show exacerbated diabetic nephropathy [21], broadening our understanding of the systemic roles of APOC3 and its implications in metabolic diseases. This evidence concerns the gene APOC3 and diabetic kidney disease.